VORICONAZOLE-ZP voriconazole 200mg tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

voriconazole, Quantity: 200 mg

Dostępny od:

Medis Pharma Pty Ltd

INN (International Nazwa):

Voriconazole

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; microcrystalline cellulose; povidone; titanium dioxide; hypromellose; triacetin; macrogol 3350

Droga podania:

Oral

Sztuk w opakowaniu:

30, 100, 56, 10, 20, 50, 2, 14, 28

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

VORICONAZOLE-ZP is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Podsumowanie produktu:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2015-02-02